Positions for Hologic Inc (NASDAQ:HOLX)

In 2018 Q3 Hologic Inc (NASDAQ:HOLX) big money sentiment increased to 0.91, SEC.gov filings reveal. That’s up 0.11, from 2018Q2’s 0.8. 159 institutional investors increased or opened new holdings, while 174 sold and reduced holdings in Hologic Inc so the sentiment is better. These funds own 259.62 million shares, that’s down from 264.98 million shares in 2018Q2. Funds holding Hologic Inc in top 10 changed to 0 from 2 for a decrease of 2. In total 35 funds closed positions, 139 reduced and 102 increased. Also 57 funds bought new Hologic Inc stakes.

Biggest Hologic Inc Shareholders

As of 2018 Q3 Domini Impact Investments Llc has 3.36% invested in Hologic Inc. As of 2018 Q3, 16.34 million shares of Hologic Inc are owned by Parnassus Investments Ca. Glenview Capital Management Llc reported 8.34 million shares. Osterweis Capital Management Inc revealed 738,545 shares position in Hologic Inc. The California-based fund Endurant Capital Management Lp holds 93,045 shares or 1.7% of their stocks portfolio.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally.The firm is valued at $13.90 billion. It operates through four divisions: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.Last it reported negative earnings. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, Procleix family of assays for blood screening, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test.

Ticker’s shares touched $47.72 during the last trading session after 1.21% change.Hologic, Inc. has volume of 185,297 shares. Since March 1, 2018 HOLX has risen 1.68% and is uptrending. The stock outperformed the S&P500 by 1.68%.

Lombard Odier Asset Management (Usa) Corporation invested in 0.07% or 25,000 shs. Guardian Life Insurance Of America holds 782 shs or 0.01% of its capital. Natl Registered Inv Advisor Inc has 7,975 shs for 0.17% of their capital. Sun Life has invested 0.01% in Hologic, Inc. (NASDAQ:HOLX). 110,212 were accumulated by Bokf Na. Mirae Asset Glob Invests Limited invested in 35,591 shs. Bnp Paribas Arbitrage Sa holds 149,223 shs or 0% of its capital. Mutual Of America Capital Mngmt Limited Co, a New York-based fund reported 35,204 shs. Stratos Wealth Prtn Limited holds 4,524 shs or 0.01% of its capital. The Massachusetts-based Boston Private Wealth Limited has invested 0.07% in Hologic, Inc. (NASDAQ:HOLX). Price T Rowe Md holds 0.28% or 46.60M shs. First Tru Advsrs Limited Partnership, Illinois-based fund reported 273,594 shs. Metropolitan Life Co New York holds 0.03% or 38,885 shs in its capital. Trust Comm Of Vermont has 0% invested in Hologic, Inc. (NASDAQ:HOLX) for 115 shs. Optimum Inv Advsr reported 18,082 shs.

Hologic, Inc. had 10 insider sales and 0 buys since September 17, 2018. This’s net activity of $4.11 million. On Friday, November 16 Bebo Allison P also sold $273,000 worth of Hologic, Inc. (NASDAQ:HOLX). Stamoulis Christiana sold $589,950 worth of Hologic, Inc. (NASDAQ:HOLX) on Wednesday, November 28. Another trade for 546 shs valued at $21,818 was sold by Oberton Karleen Marie. CRAWFORD SALLY sold $524,169 worth of stock or 13,257 shs. Valenti Peter J. III sold $200,028 worth of Hologic, Inc. (NASDAQ:HOLX) on Friday, December 7.

Hologic, Inc. (NASDAQ:HOLX) Ratings Coverage

Total analysts of 6 have positions in Hologic (NASDAQ:HOLX) as follows: 0 rated it a “Buy”, 1 with “Sell” and 5 with “Hold”. The positive are 0. Since September 5, 2018 according to StockzIntelligence Inc Hologic has 8 analyst reports. In Thursday, September 13 report Bank of America downgraded it to “Neutral” rating and $42 target. In Wednesday, January 2 report Morgan Stanley downgraded the stock to “Underweight” rating. On Friday, November 30 the rating was maintained by RBC Capital Markets with “Sector Perform”. On Thursday, September 13 the stock of Hologic, Inc. (NASDAQ:HOLX) has “Hold” rating given by Canaccord Genuity. On Friday, January 4 the firm has “Market Perform” rating given by Cowen & Co. On Thursday, September 27 the stock of Hologic, Inc. (NASDAQ:HOLX) has “Hold” rating given by Canaccord Genuity. On Thursday, October 11 the firm earned “Equal-Weight” rating by Morgan Stanley. In Wednesday, September 5 report Barclays Capital downgraded it to “Equal-Weight” rating and $43 target.

For more Hologic, Inc. (NASDAQ:HOLX) news announced recently go to: Nasdaq.com, Seekingalpha.com, Benzinga.com, Nasdaq.com or Investorplace.com. The titles are as follows: “After-Hours Earnings Report for January 30, 2019 : MSFT, FB, V, PYPL, MDLZ, QCOM, TSLA, NOW, ESS, AMP, HOLX, WYNN – Nasdaq” announced on January 30, 2019, “Hologic FQ1 top line up 5%; guidance raised – Seeking Alpha” on January 30, 2019, “The Daily Biotech Pulse: Hologic, Celgene Earnings, FDA To Rule On Alkermes Depression Drug – Benzinga” with a publish date: January 31, 2019, “Hologic’s (HOLX) Q1 Earnings Beat Estimates, Guidance Raised – Nasdaq” and the last “3 Big Stock Charts for Friday: PulteGroup, Microsoft and Hologic – Investorplace.com” with publication date: February 01, 2019.